Nomogram for overall survival of Japanese patients with bone-metastatic prostate cancer

le Miyoshi, Yasuhide, Noguchi, Kazumi, Yanagisawa, Masahiro, Taguri, Masataka, Morita, Satoshi, Ikeda, Ichiro, Fujinami, Kiyoshi, Miura, Takeshi, Kobayashi, Kazuki, Uemura, Hiroji
Foilsithe in BMC Cancer (2015)

A higher De Ritis ratio (AST/ALT) is a risk factor for progression in high-risk non-muscle invasive bladder cancer

le Fukui-Kawaura, Sachi, Kawahara, Takashi, Araki, Yushi, Nishimura, Reona, Uemura, Koichi, Namura, Kazuhiro, Mizuno, Nobuhiko, Yao, Masahiro, Uemura, Hiroji, Ikeda, Ichiro
Foilsithe in Oncotarget (2021)

The acceleration of glucose accumulation in renal cell carcinoma assessed by FDG PET/CT demonstrated acquisition of resistance to tyrosine kinase inhibitor therapy

le Nakaigawa, Noboru, Kondo, Keiichi, Ueno, Daiki, Namura, Kazuhiro, Makiyama, Kazuhide, Kobayashi, Kazuki, Shioi, Koichi, Ikeda, Ichiro, Kishida, Takeshi, Kaneta, Tomohiro, Minamimoto, Ryogo, Tateishi, Ukihide, Inoue, Tomio, Yao, Masahiro
Foilsithe in BMC Cancer (2017)

FDG PET/CT as a prognostic biomarker in the era of molecular-targeting therapies: max SUVmax predicts survival of patients with advanced renal cell carcinoma

le Nakaigawa, Noboru, Kondo, Keiichi, Tateishi, Ukihide, Minamimoto, Ryogo, Kaneta, Tomohiro, Namura, Kazuhiro, Ueno, Daiki, Kobayashi, Kazuki, Kishida, Takeshi, Ikeda, Ichiro, Hasumi, Hisashi, Makiyama, Kazuhide, Kubota, Yoshinobu, Inoue, Tomio, Yao, Masahiro
Foilsithe in BMC Cancer (2016)

Early assessment by FDG-PET/CT of patients with advanced renal cell carcinoma treated with tyrosine kinase inhibitors is predictive of disease course

le Ueno, Daiki, Yao, Masahiro, Tateishi, Ukihide, Minamimoto, Ryogo, Makiyama, Kazuhide, Hayashi, Narihiko, Sano, Futoshi, Murakami, Takayuki, Kishida, Takeshi, Miura, Takeshi, Kobayashi, Kazuki, Noguchi, Sumio, Ikeda, Ichiro, Ohgo, Yoshiharu, Inoue, Tomio, Kubota, Yoshinobu, Nakaigawa, Noboru
Foilsithe 2012

The early response of renal cell carcinoma to tyrosine kinase inhibitors evaluated by FDG PET/CT was not influenced by metastatic organ

le Kakizoe, Manabu, Yao, Masahiro, Tateishi, Ukihide, Minamimoto, Ryogo, Ueno, Daiki, Namura, Kazuhiro, Makiyama, Kazuhide, Hayashi, Narihiko, Sano, Futoshi, Kishida, Takeshi, Kobayashi, Kazuki, Noguchi, Sumio, Ikeda, Ichiro, Ohgo, Yoshiharu, Taguri, Masataka, Morita, Satoshi, Inoue, Tomio, Kubota, Yoshinobu, Nakaigawa, Noboru
Foilsithe 2014

Early assessment with (18)F-2-fluoro-2-deoxyglucose positron emission tomography/computed tomography to predict short-term outcome in clear cell renal carcinoma treated with nivolu...

le Tabei, Tadashi, Nakaigawa, Noboru, Kaneta, Tomohiro, Ikeda, Ichiro, Kondo, Keiichi, Makiyama, Kazuhide, Hasumi, Hisashi, Hayashi, Narihiko, Kawahara, Takashi, Izumi, Koji, Osaka, Kimito, Muraoka, Kentaro, Teranishi, Jun-ichi, Miyoshi, Yasuhide, Yumura, Yasushi, Uemura, Hiroji, Kobayashi, Kazuki, Inoue, Tomio, Yao, Masahiro
Foilsithe in BMC Cancer (2019)

Plasma Free Amino Acid Profiling of Five Types of Cancer Patients and Its Application for Early Detection

le Miyagi, Yohei, Higashiyama, Masahiko, Gochi, Akira, Akaike, Makoto, Ishikawa, Takashi, Miura, Takeshi, Saruki, Nobuhiro, Bando, Etsuro, Kimura, Hideki, Imamura, Fumio, Moriyama, Masatoshi, Ikeda, Ichiro, Chiba, Akihiko, Oshita, Fumihiro, Imaizumi, Akira, Yamamoto, Hiroshi, Miyano, Hiroshi, Horimoto, Katsuhisa, Tochikubo, Osamu, Mitsushima, Toru, Yamakado, Minoru, Okamoto, Naoyuki
Foilsithe 2011

Androgen deprivation therapy prevents bladder cancer recurrence

le Izumi, Koji, Taguri, Masataka, Miyamoto, Hiroshi, Hara, Yoshinori, Kishida, Takeshi, Chiba, Kimio, Murai, Tetsuo, Hirai, Kotaro, Suzuki, Kotaro, Fujinami, Kiyoshi, Ueki, Teiichiro, Udagawa, Koichi, Kitami, Kazuo, Moriyama, Masatoshi, Miyoshi, Yasuhide, Tsuchiya, Futoshi, Ikeda, Ichiro, Kobayashi, Kazuki, Sato, Maho, Morita, Satoshi, Noguchi, Kazumi, Uemura, Hiroji
Foilsithe in Oncotarget (2014)